Inogen Inc (INGN)

Name: Inogen Inc (INGN) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Inogen Inc (INGN)

Stock Card

$5.50

$-0.01 (-0.18%)

As on 28-Aug-2026 16:00EDT

Market cap

$146 Mln

Revenue (TTM)

$354 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

Inogen (INGN) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.46 High: 5.66

52 Week Range

Low: 5.34 High: 9.13

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.1 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-17.6
Debt to Equity

0
Book Value

$6.5
EPS

$-0.9
Face value

--
Shares outstanding

26,538,337

10 Years Aggregate

CFO

$265.84 Mln

EBITDA

$172.75 Mln

Net Profit

$-65.66 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Inogen (INGN)	-18.2	-12.8	-16.4	-30.6	-2.8	-37.9	-20.9
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Inogen (INGN)	-26.7	66.3	-72.1	-42.0	-23.9	-34.6	-45.0
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Inogen (INGN)	5.5	146.0	354.3	-24.6	-7.1	-13.4	--	0.8
10X Genomics Inc (TXG)	61.5	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	179.9	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Merit Medical Systems (MMSI)	90.5	5,403.2	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	321.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	176.3	9,947.9	785.1	41.5	9.9	2	251.8	4.9

Shareholding Pattern

View Details

About Inogen (INGN)

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen... therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts. Read more

Executive VP, General Counsel & Corporate Secretary

Mr. Jason Somer
Executive VP, General Counsel & Corporate Secretary

Mr. Jason Somer
Headquarters

Beverly, MA
Website

https://www.provider.inogen.com

FAQs for Inogen (INGN)

What is the current share price of Inogen Inc (INGN) Today?

The share price of Inogen Inc (INGN) is $5.50 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Inogen Inc (INGN) has given a return of -2.8% in the last 3 years.

What is the current PB & PE ratio of Inogen Inc (INGN)?

Since, TTM earnings of Inogen Inc (INGN) is negative, P/E ratio is not available.
The P/B ratio of Inogen Inc (INGN) is 0.83 times as on 28-Aug-2026, a 78 discount to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.